Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 10 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Mirum Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- +2 vs. Q2 2022
- Shares held
- 33.7M
- +4.42M (+15.1%) vs. Q2 2022
- Total value
- $709.1M
- +$139.7M (+24.5%) vs. Q2 2022
- New holders
- 17
- 48 more added
- Sold out
- 15
- 28 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 326 | $8.36B |
| Q1 2026 | 311 | $6.29B |
| Q4 2025 | 284 | $4.82B |
| Q3 2025 | 272 | $4.20B |
| Q2 2025 | 214 | $2.82B |
| Q1 2025 | 214 | $2.44B |
| Q4 2024 | 205 | $2.19B |
| Q3 2024 | 178 | $2.08B |
| Q2 2024 | 161 | $1.83B |
| Q1 2024 | 172 | $1.34B |
| Q4 2023 | 187 | $1.48B |
| Q3 2023 | 159 | $1.55B |
| Q2 2023 | 146 | $955.6M |
| Q1 2023 | 117 | $832.9M |
| Q4 2022 | 104 | $650.2M |
| Q3 2022 | 112 | $709.1M |
| Q2 2022 | 110 | $569.4M |
| Q1 2022 | 99 | $590.4M |
| Q4 2021 | 86 | $395.7M |
| Q3 2021 | 73 | $465.0M |
| Q2 2021 | 67 | $404.6M |
| Q1 2021 | 61 | $463.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Mirum Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,244,925 | $26.2M | 0.00% | +261,950+26.6% | Added |
| Eventide Asset Management, LLC | 1,275,000 | $26.8M | 0.53% | +1,275,000 | New |
| Cadian Capital Management, LP | 1,364,786 | $28.7M | 1.68% | −21,211−1.5% | Reduced |
| Franklin Resources Inc | 1,536,124 | $32.3M | 0.02% | +287,002+23.0% | Added |
| Novo Holdings A/S | 1,684,193 | $35.4M | 1.70% | −343,131−16.9% | Reduced |
| BlackRock Inc. | 1,749,349 | $36.8M | 0.00% | +353,337+25.3% | Added |
| Rock Springs Capital Management LP | 1,795,733 | $37.7M | 0.97% | +78,000+4.5% | Added |
| RiverVest Venture Management LLC | 1,921,118 | $40.4M | 46.86% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,032,335 | $42.7M | 0.85% | −1,212,099−37.4% | Reduced |
| Frazier Life Sciences Management, L.P. | 3,827,781 | $80.4M | 6.19% | +260,869+7.3% | Added |
| NEA Management Company, LLC | 4,187,801 | $88.0M | 4.39% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 15 | – | – | −15−50.0% | Reduced |
| EAM Investors, LLC | 0 | $0 | 0.00% | −95,607−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −61,233−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −42,349−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −41,500−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −34,971−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −22,337−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −16,607−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −14,659−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −10,960−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,476−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −773−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Raffa Wealth Management, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −8−100.0% | Sold out |